India’s Cumulative COVID-19 Vaccination Coverage exceeds 143.15 Cr

Vaccine injection. Syringe with medicine in the hands of a doctor in blue gloves. Prophylaxis and treatment of infectious and viral diseases. Inoculation against influenza. Vaccination against rabies.

New Delhi : With the administration of 64,61,321 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 143.15 Cr (1,43,15,35,641) as per provisional reports till 7 am today. This has been achieved through 1,52,69,126 sessions.

The break-up of the cumulative figure as per the provisional report till 7 am today include:



1st Dose 1,03,87,197
2nd Dose 96,94,283


1st Dose 1,83,85,217
2nd Dose 1,68,62,710

Age Group 18-44 years

1st Dose 49,64,04,904
2nd Dose 32,31,01,947

Age Group 45-59 years

1st Dose 19,38,12,980
2nd Dose 14,80,52,758

Over 60 years

1st Dose 12,09,96,702
2nd Dose 9,38,36,943
Total 1,43,15,35,641

The recovery of 7,347 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,42,51,292.

Consequently, India’s recovery rate stands at 98.40%, highest since March 2020.

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 15,000 Daily New Cases that is being reported for last 62 days now.

9,195 new cases were reported in the last 24 hours.

India’s Active Caseload is presently at 77,002. Active cases constitute 0.22% of the country’s total Positive Cases, which is lowest since March 2020.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 11,67,612 tests being conducted. India has so far conducted over 67.52 Cr (67,52,46,143) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 0.68% remains less than 1% for the last 45 days now. The Daily Positivity rate reported to be 0.79%. The daily Positivity rate has remained below 2% for last 86 days and below 3% for 121 consecutive days now.

Comments are closed.